FDA AUTHORIZED REPORTS INCLUDED

Ancestry + Traits
Service

Price:$99
  • 1500+ Geographic regions
  • Automatic Family Tree Builder
  • 30+ Trait reports
  • DNA Relative Finder

Health + Ancestry
Service

Price:$199
  • Includes everything in Ancestry + Traits Service

    PLUS

  • 10+ Health Predisposition reports*
  • 5+ Wellness reports
  • 40+ Carrier Status reports*

VIP Health + Ancestry
Service

Price:$499
  • Includes 2 Health + Ancestry Service kits

    PLUS

  • Overnight shipping
  • Priority lab processing
  • Premium customer support
  • 1-on-1 Ancestry results walkthrough
Priority lab processing, premium customer support and 30-minute phone Ancestry results walkthrough are valid for 1 year from the date of purchase.
Hi, we're 23andMe

We're all about real science, real data and genetic insights that positively impact people's lives.

150+ personalized
DNA reports
Private and
protected
10+ million DNA test
kits sold
Breakthrough
research

Three paths. One
destination.
You.

FeatureAncestry + Traits ServiceHealth + Ancestry ServiceVIP Health + Ancestry Service

Ancestry + Traits
Service

Price:$99
Add to cart
Recommended

Health + Ancestry
Service

Price:$199
Add to cartImportant test info

VIP Health + Ancestry Service

Price:$499
Add to cartImportant test info
Total reports80+150+150+
Ancestry reportsincludedincludedincluded
Family Treeincludedincludedincluded
DNA Relative Finder
includedincludedincluded
Trait reports
includedincludedincluded
Health Predisposition reports*
not includedincludedincluded
Carrier Status reports*
not includedincludedincluded
Wellness reports
not includedincludedincluded
VIP features
not includednot includedincluded

Privacy
Know that we have your back.

Discovery should never come at the expense of privacy. Your data is encrypted, protected and under your control. You decide what you want to know and what you want to share.

Learn more

Research

Know you're making a difference.

When you opt in to participate in our research, you join forces with millions of other people contributing to science. Your participation could help lead to discoveries that may one day make an impact on your own health, the health of your family and ultimately, people around the world. (Look at you go.)

Learn more

Stay in the know.

Keep up-to-date with new discoveries and exclusive promotions on our DNA test kits.

*The 23andMe PGS test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future, the health of your fetus, or your newborn child's risk of developing a particular disease later in life. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. Warnings & Limitations: The 23andMe PGS Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants) is indicated for reporting of the 185delAG and 5382insC variants in the BRCA1 gene and the 6174delT variant in the BRCA2 gene. The report describes if a woman is at increased risk of developing breast and ovarian cancer, and if a man is at increased risk of developing breast cancer or may be at increased risk of developing prostate cancer. The three variants included in this report are most common in people of Ashkenazi Jewish descent and do not represent the majority of BRCA1/BRCA2 variants in the general population. This report does not include variants in other genes linked to hereditary cancers and the absence of variants included in this report does not rule out the presence of other genetic variants that may impact cancer risk. The PGS test is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up. Results should be confirmed in a clinical setting before taking any medical action. For important information and limitations regarding each genetic health risk and carrier status report, visit 23andme.com/test-info/

Priority lab processing, premium customer support and 30-minute phone Ancestry results walkthrough are valid for 1 year from the date of purchase.